Extremely Thermostabilizing Core Mutations in Coiled-Coil Mimetic Proteins of HIV-1 gp41 Produce Diverse Effects on Target Binding but Do Not Affect Their Inhibitory Activity.
AIDS
HIV
binding
calorimetry
envelope glycoprotein
fusion inhibitors
peptides
stability
Journal
Biomolecules
ISSN: 2218-273X
Titre abrégé: Biomolecules
Pays: Switzerland
ID NLM: 101596414
Informations de publication
Date de publication:
12 04 2021
12 04 2021
Historique:
received:
22
03
2021
revised:
05
04
2021
accepted:
09
04
2021
entrez:
30
4
2021
pubmed:
1
5
2021
medline:
18
9
2021
Statut:
epublish
Résumé
A promising strategy to neutralize HIV-1 is to target the gp41 spike subunit to block membrane fusion with the cell. We previously designed a series of single-chain proteins (named covNHR) that mimic the trimeric coiled-coil structure of the gp41 N-terminal heptad repeat (NHR) region and potently inhibit HIV-1 cell infection by avidly binding the complementary C-terminal heptad repeat (CHR) region. These proteins constitute excellent tools to understand the structural and thermodynamic features of this therapeutically important interaction. Gp41, as with many coiled-coil proteins, contains in core positions of the NHR trimer several highly conserved, buried polar residues, the role of which in gp41 structure and function is unclear. Here we produced three covNHR mutants by substituting each triad of polar residues for the canonical isoleucine. The mutants preserve their helical structure and show an extremely increased thermal stability. However, increased hydrophobicity enhances their self-association. Calorimetric analyses show a marked influence of mutations on the binding thermodynamics of CHR-derived peptides. The mutations do not affect however the in vitro HIV-1 inhibitory activity of the proteins. The results support a role of buried core polar residues in maintaining structural uniqueness and promoting an energetic coupling between conformational stability and NHR-CHR binding.
Identifiants
pubmed: 33921495
pii: biom11040566
doi: 10.3390/biom11040566
pmc: PMC8069472
pii:
doi:
Substances chimiques
Anti-HIV Agents
0
HIV Envelope Protein gp41
0
Oligopeptides
0
Isoleucine
04Y7590D77
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : State Research Agency of Spain, SRA/10.13039/501100011033
ID : BIO2016-76640-R and PID2019.107515RB.C21
Organisme : ERDF/ESF, "A way to make Europe"/"Investing in your future"
ID : n/a
Références
Curr Top Med Chem. 2016;16(10):1074-90
pubmed: 26324044
Nat Struct Biol. 1996 Dec;3(12):1011-8
pubmed: 8946854
Science. 2001 Feb 2;291(5505):884-8
pubmed: 11229405
Nat Struct Mol Biol. 2009 Jul;16(7):684-90
pubmed: 19525973
Annu Rev Immunol. 2020 Apr 26;38:673-703
pubmed: 32340576
Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):16828-33
pubmed: 17942675
J Immunol Methods. 2014 Jul;409:131-46
pubmed: 24291345
AIDS Rev. 2004 Jan-Mar;6(1):61
pubmed: 15168742
J Mol Biol. 2020 Sep 18;432(20):5577-5592
pubmed: 32822695
J Biol Chem. 2001 Aug 3;276(31):29485-9
pubmed: 11418583
Nature. 1997 May 22;387(6631):426-30
pubmed: 9163431
Curr HIV Res. 2016;14(3):283-94
pubmed: 26957202
PLoS Pathog. 2009 Nov;5(11):e1000674
pubmed: 19956769
AIDS Rev. 2005 Jul-Sep;7(3):139-47
pubmed: 16302461
Immunol Rev. 2017 Jan;275(1):21-32
pubmed: 28133813
HIV Med. 2019 Aug;20(7):429-438
pubmed: 31006976
J Mol Biol. 2019 Aug 9;431(17):3091-3106
pubmed: 31255705
Biology (Basel). 2012 Aug 20;1(2):311-38
pubmed: 23730525
Cell. 1997 Apr 18;89(2):263-73
pubmed: 9108481
Proc Natl Acad Sci U S A. 2008 Oct 21;105(42):16332-7
pubmed: 18852475
Subcell Biochem. 2017;82:35-61
pubmed: 28101858
Viruses. 2014 Oct 24;6(10):4095-139
pubmed: 25341668
Nucleic Acids Res. 2003 Jul 1;31(13):3784-8
pubmed: 12824418
J Biol Chem. 2018 Aug 17;293(33):12703-12718
pubmed: 29929981
Nat Med. 1998 Nov;4(11):1302-7
pubmed: 9809555
Viruses. 2019 Aug 01;11(8):
pubmed: 31374953
Chembiochem. 2004 Feb 6;5(2):170-6
pubmed: 14760737
Arch Biochem Biophys. 2020 Jul 30;688:108401
pubmed: 32376316
Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11187-92
pubmed: 11572974
Science. 2016 May 6;352(6286):680-7
pubmed: 27151862
Cell. 1998 May 29;93(5):681-4
pubmed: 9630213
Curr Top Membr. 2011;68:81-106
pubmed: 21771496
J Am Chem Soc. 2006 Apr 5;128(13):4170-1
pubmed: 16568959
Biochemistry. 2000 Feb 1;39(4):676-85
pubmed: 10651632
J Biol Chem. 2010 Aug 13;285(33):25506-15
pubmed: 20538590
Biochemistry. 2001 May 29;40(21):6352-60
pubmed: 11371197
J Biol Chem. 2006 Sep 1;281(35):25813-21
pubmed: 16803885
Proc Natl Acad Sci U S A. 2014 Dec 23;111(51):18207-12
pubmed: 25489108